Many Canadian patients are affected by osteoporosis and osteoporotic fractures, which can cause chronic pain, reduced mobility, and be irreversibly debilitating. The CAR is collaborating on a project with 16 Bit, GE HealthCare Canada, Osteoporosis Canada, True North Imaging, and the Centre for Technology Adoption for Aging in the North aimed at screening for indications of low bone mineral density using Artificial Intelligence (AI) software called RhoTM.
“Rho utilizes a deep convolutional neural network to assign a Rho Score that corresponds to a patient’s likelihood of having low bone mineral density. If Rho detects that a patient likely has low BMD, a Rho Report is sent to the radiologist. The radiologist can choose to include Rho findings in their report. The referring physician can then conduct a clinical fracture risk assessment, and, if necessary, refer the patient for a DXA.”
The project is a 3-year program to pilot Rho in clinical environments in Canada to obtain experiential reviews and product feedback from key stakeholders, enabling them to evaluate the impact of Rho on their clinical practice and patient outcomes.
In addition to the collaborators, INOVAIT will contribute $2 million through their Focus Fund, supported by the Government of Canada’s Strategic Innovation Fund.